[{"path":"/articles/clinical-significance-cutoffs.html","id":"jacobson-truax","dir":"Articles","previous_headings":"","what":"Jacobson & Truax","title":"Clinical Significance Cutoffs","text":"imagine dimensional outcome, e.g., measure depression, clinical functional population form two distinct distributions dimension. specific example (see figure ), clinical population (red line) can described normal distribution M = 32 SD = 7. functional population (blue line) can described normal distribution M = 10 SD = 7.","code":""},{"path":"/articles/clinical-significance-cutoffs.html","id":"a-and-b","dir":"Articles","previous_headings":"Jacobson & Truax","what":"a and b","title":"Clinical Significance Cutoffs","text":"reasonable cutoff clinical functional population ly . Jacobson et al. (1984) Jacobson & Truax (1991) proposed cutoffs \\(\\) \\(b\\) \\[= M_{clin} - 2 SD_{clin}\\\\= 32 - 2\\cdot7\\\\=18\\] \\[b = M_{fun} + 2 SD_{clin}\\\\b=10+2\\cdot7\\\\b=24\\] \\(M_{clin}\\) \\(M_{fun}\\) means clinical functional population \\(SD_{clin}\\) standard deviation clinical population. note cutoffs incorporate clinical population’s standard deviation “starting point” different. \\(\\), clinical population’s mean \\(b\\) functional population’s mean. importance direction beneficial effect. example, lower depression score beneficial patient. examples, opposite may true, e.g., measure quality life, higher values desirable. case, plus minus signs formulas switched. incorporate cutoffs \\(\\) \\(b\\) figure , get following picture.  overlapping distributions, \\(\\) seems conservative \\(b\\) seems liberal deciding whether patient moved clinical functional population.","code":""},{"path":"/articles/clinical-significance-cutoffs.html","id":"c","dir":"Articles","previous_headings":"Jacobson & Truax","what":"c","title":"Clinical Significance Cutoffs","text":"reasonable cutoff, however, may one incorporates , mean standard deviation, populations. \\(c\\) designed . defined \\[c = \\frac{SD_{fun}M_{clin} + SD_{clin}M_{fun}}{SD_{fun} + SD_{clin}}\\\\c=\\frac{7\\cdot32+7\\cdot10}{7+7}\\\\c=21\\] \\(M\\) \\(SD\\) mean standard deviation indexes \\(fun\\) \\(clin\\) indicating functional clinical population. cutoff lays populations can seen figure .  , \\(c\\) generally recommended. , descriptive statistics functional population, always use \\(c\\)! ensures comparability clinical significance analyses. deviate approach, clearly explain give detailed reasons . obstacle might availability descriptives functional population needed calculate \\(c\\). However, known common instruments psychological research. , might good idea determine metrics first!","code":"distributions +   geom_vline(xintercept = c, linetype = \"dashed\") +   geom_label(aes(label = \"c\"), x = c, y = 0.05, label.r = unit(0, \"lines\"))"},{"path":"/articles/clinical-significance-cutoffs.html","id":"plot-cutoffs","dir":"Articles","previous_headings":"","what":"Plot Cutoffs","title":"Clinical Significance Cutoffs","text":"simple way check cutoffs check_cutoff()","code":"library(clinicalsignificance)  check_cutoff(m_clinical = 32, sd_clinical = 7, m_functional = 10, sd_functional = 7, type = \"c\")"},{"path":"/articles/clinical-significance-cutoffs.html","id":"hageman-arrindell","dir":"Articles","previous_headings":"","what":"Hageman & Arrindell","title":"Clinical Significance Cutoffs","text":"Hageman & Arrindell (1999) proposed \\(\\), \\(b\\), \\(c\\) expressed true scores principles classical test theory. obtain true scores \\(\\), \\(b\\), \\(c\\), .e., \\(a_{true}\\), \\(b_{true}\\), \\(c_{true}\\), standard deviations formulas proposed Jacobson & Truax (1991) must multiplied respective reliability. \\[a_{true} = M_{clin} - 2 SD_{clin} \\sqrt{r_{xx(clin)}}\\] \\[\\sqrt{r_{xx(clin)}} = \\frac{SD_{clin}^2 - S_E}{SD_{clin}^2}\\] \\[S_E = SD_{sample}\\sqrt{1 - r_{sample}}\\] \\(SD_{sample}\\) \\(r_{sample}\\) standard deviation reliability coefficient specific sample. sample may clinical functional population. reliability coefficient , , measure internal consistency. \\(b_{true}\\) defined \\[b_{true} = M_{fun} + 2 SD_{clin}\\sqrt{r_{xx(clin)}}\\] Bear mind direction beneficial importance well. formulas outcome lower score indicates beneficial outcome. higher values desirable, plus minus signs formulas \\(a_{true}\\) \\(b_{true}\\) must switched. \\(c_{true}\\) defined \\[c_{true} = \\frac{SD_{fun}\\sqrt{r_{xx(fun)}}M_{clin} + SD_{clin}\\sqrt{r_{xx(clin)}}M_{fun}}{SD_{fun}\\sqrt{r_{xx(fun)}} + SD_{clin}\\sqrt{r_{xx(clin)}}}\\] \\[\\sqrt{r_{xx(fun)}} = \\frac{SD_{fun}^2 - S_E}{SD_{fun}^2}\\]","code":""},{"path":"/articles/clinical-significance-plot.html","id":"clinical-significance-plot","dir":"Articles","previous_headings":"","what":"Clinical Significance Plot","title":"Clinical Significance Plots","text":"","code":"anxiety_results <- anxiety %>%    clinical_significance(     id = subject,      time = measurement,      outcome = anxiety,      pre = 0,      post = 4,      reliability = 0.80,      m_functional = 10,      sd_functional = 7,      type = \"c\"   )  plot(anxiety_results, upper_limit = 60)"},{"path":"/articles/clinical-significance-plot.html","id":"interpretation","dir":"Articles","previous_headings":"","what":"Interpretation","title":"Clinical Significance Plots","text":"lower instrument score corresponds beneficial outcome, categories clinical significance plot can interpreted according figure .  higher instrument score corresponds beneficial outcome, categories clinical significance plot can interpreted according figure . plot , flipped along diagonal indicates change.","code":""},{"path":"/articles/clinical-significance-plot.html","id":"different-methods","dir":"Articles","previous_headings":"","what":"Different Methods","title":"Clinical Significance Plots","text":"plot automatically changes according specified clinical significance method.   clinical significance analyses employing HLM method (Raudenbush & Bryk, 2002), individual trajectories empirical Bayes slopes can plotted well.","code":"anxiety_results_ha <- anxiety %>%    clinical_significance(     id = subject,      time = measurement,      outcome = anxiety,      pre = 0,      post = 4,      reliability = 0.80,      m_functional = 10,      sd_functional = 7,      type = \"c\",     method = \"HA\"   )  plot(anxiety_results_ha, upper_limit = 60) anxiety_results_en <- anxiety %>%    clinical_significance(     id = subject,      time = measurement,      outcome = anxiety,      pre = 0,      post = 4,      reliability = 0.80,      m_functional = 10,      sd_functional = 7,      type = \"c\",     method = \"EN\"   )  plot(anxiety_results_en, upper_limit = 60) anxiety_results_hlm <- anxiety %>%    clinical_significance(     id = subject,     time = measurement,     outcome = anxiety,     method = \"HLM\"   )  plot(anxiety_results_hlm, which = \"trajectory\") plot(anxiety_results_hlm, which = \"slope\")"},{"path":[]},{"path":"/articles/clinical-significance-plot.html","id":"colors","dir":"Articles","previous_headings":"Plot Options","what":"Colors","title":"Clinical Significance Plots","text":"can choose different categories groups colored separately. clinical significance analysis contains grouping variable, automatically shown corresponding plot.  Alternatively, can color individual clinical significance categories.   categories .  Trajectories slopes HLM can colored well.   clinicalsignificance uses ggplot2 internally, can manipulate plots liking.","code":"anxiety_results_grouped <- anxiety %>%    clinical_significance(     id = subject,      time = measurement,      outcome = anxiety,      pre = 0,      post = 4,      reliability = 0.80,      m_functional = 10,      sd_functional = 7,      type = \"c\",     group = treatment   )  plot(anxiety_results_grouped, upper_limit = 60) plot(anxiety_results, upper_limit = 60, show = \"recovered\") plot(anxiety_results, upper_limit = 60, show = \"improved\") plot(anxiety_results, upper_limit = 60, show = \"category\") plot(anxiety_results_hlm, which = \"trajectory\", show = \"recovered\") plot(anxiety_results_hlm, which = \"slope\", show = \"recovered\") plot(anxiety_results_hlm, which = \"trajectory\", show = \"recovered\") +   facet_wrap(~ recovered) +   theme_minimal()"},{"path":"/articles/clinical-significance-plot.html","id":"rci-fill","dir":"Articles","previous_headings":"Plot Options","what":"RCI Fill","title":"Clinical Significance Plots","text":"can change display RCI band, .e., color transparency.  HA method (Hageman & Arrindell, 1999) considers band around post measurement cutoff, can plotted well.","code":"plot(anxiety_results, upper_limit = 60, rci_fill = \"blue\", rci_alpha = 0.2) plot(anxiety_results_ha, upper_limit = 60, include_cutoff_band = TRUE)"},{"path":"/articles/clinical-significance-plot.html","id":"cutoffs","dir":"Articles","previous_headings":"Plot Options","what":"Cutoffs","title":"Clinical Significance Plots","text":"recommended include cutoff clinical functional population. default, plotted can omitted well.","code":"plot(anxiety_results, upper_limit = 60, include_cutoff = FALSE)"},{"path":"/articles/clinical-significance-plot.html","id":"labels","dir":"Articles","previous_headings":"Plot Options","what":"Labels","title":"Clinical Significance Plots","text":"default, generic plot labels used. can adjust make figure publication ready.","code":"plot(anxiety_results_grouped,       upper_limit = 60,       x_lab = \"Anxiety Pre\",       y_lab = \"Anxiety Post\",       color_lab = \"Condition\")"},{"path":[]},{"path":"/articles/clinicalsignificance.html","id":"a-typical-example","dir":"Articles","previous_headings":"","what":"A Typical Example","title":"Get started","text":"Suppose intervention enhances placebo effect antidepressants routine care. Claus et al. (2020) conducted study examining intervention routine care setting depressive disorders comparing group patients receiving treatment usual (TAU) group patients receiving placebo amplification intervention (PA). assessed patients four times treatment measurements carried pre treatment, two times treatment one time post treatment. original study data included package claus_2020. mainly contains column identifying individual patients (id), column indicating measurement (time values 1–4), four outcomes assessed (bdi, shaps, , hamd), well column indicating experimental condition (treatment two experimental conditions TAU PA). Let’s consider primary outcome study, Beck Depression Inventory second edition (Beck et al., 1996), known BDI-II. scores per patient measurement can found column bdi. First, let’s plot results. load tidyverse, gain access package ggplot2 others data wrangling.  can see BDI-II scores seemed declining course treatment. effect meaningful practical patients?","code":"library(clinicalsignificance)  claus_2020 #> # A tibble: 172 × 9 #>       id   age sex    treatment  time   bdi shaps   who  hamd #>    <dbl> <dbl> <fct>  <fct>     <dbl> <dbl> <dbl> <dbl> <dbl> #>  1     1    54 Male   TAU           1    33     9     0    25 #>  2     1    54 Male   TAU           2    28     6     3    17 #>  3     1    54 Male   TAU           3    28     9     7    13 #>  4     1    54 Male   TAU           4    27     8     3    13 #>  5     2    52 Female PA            1    26    11     2    15 #>  6     2    52 Female PA            2    26    10     0    16 #>  7     2    52 Female PA            3    25    10     0     7 #>  8     2    52 Female PA            4    19     9     3    11 #>  9     3    54 Male   PA            1    15     2     0    28 #> 10     3    54 Male   PA            2    13     5     9    17 #> # … with 162 more rows library(tidyverse)  claus_2020 %>%    mutate(time = as_factor(time)) %>%    ggplot(aes(time, bdi)) +   geom_boxplot() #> Warning: Removed 9 rows containing non-finite values (stat_boxplot)."},{"path":"/articles/clinicalsignificance.html","id":"clinical-significance","dir":"Articles","previous_headings":"","what":"Clinical Significance","title":"Get started","text":"Additionally statistical significance testing, clinical significance testing great way make sense results . , can examine given patient changes reliably crosses line clinical functional population practical relevance patient. functional population particular example examined Kühner et al. (2007), determined mean BDI-II score M = 7.69 (SD = 7.52) non-clinical German population. study Claus et al. (2020), reliability BDI-II McDonald’s \\(\\omega\\) = 0.801. values, information need calculate clinical significance clinical_significance(). Note Claus et al. (2020) assessed patients four times study, clinical significance analysis usually done pre post assessments alone (exception HLM method), need specify pre assessment (pre = 1) post assessment (post = 4). now can see 10 patients categorized recovered. means 10 patients clinical population pre intervention functional population post treatment showed reliable change. 8 patients showed reliable change change clinical functional population. 22 patients change reliably – change greater error measurement. Fortunately, patients deteriorated harmed study period. can obtain detailed summary incorporated calculated values summary(). can see 40 participants sufficient data used analysis (pre post scores). given chosen cutoff (\"c\") well value (21.02). Additionally, can plot results plot(). know upper limit BDI-II 63, can specify make plot comprehensible.  wish, can plot clinical significance categories well.","code":"results <- claus_2020 %>%    clinical_significance(     id = id,     time = time,     outcome = bdi,     pre = 1,     post = 4,     m_functional = 7.69,     sd_functional = 7.52,     reliability = 0.801,     type = \"c\"   )  results #> Clinical Significance Results (JT) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.250 #> Improved     |  8 |   0.200 #> Unchanged    | 22 |   0.550 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 summary(results) #>  #> Clinical Significance Results #>  #> There were 43 participants in the whole dataset of which #> 40 (93%) could be included in the analysis. #>  #> The JT method for calculating cutoffs and reliable change was #> chosen and the outcome variable was \"bdi\". #>  #> The cutoff type was \"c\" with a value of 21.02 based on #> the following population characteristics (with lower values #> representing a beneficial outcome): #>  #> Population Characteristics #>  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 35.48      | 8.16        | 7.69         | 7.52          #>  #>  #> The instrument's reliability was set to 0.8  #>  #> Individual Level Results #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.250 #> Improved     |  8 |   0.200 #> Unchanged    | 22 |   0.550 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 plot(results, upper_limit = 63) plot(results, upper_limit = 63, show = \"category\")"},{"path":"/articles/clinicalsignificance.html","id":"grouped-data","dir":"Articles","previous_headings":"Clinical Significance","what":"Grouped Data","title":"Get started","text":"study compared two groups (TAU PA) latter one receiving intervention interest, grouping variable can specified well. function call identical call exception provide column containing groups (treatment data set). output, can see patients recovered improved PA group (intervention) compared TAU group (control). patients categorized unchanged TAU group PA group. results can also plotted.","code":"results_grouped <- claus_2020 %>%    clinical_significance(     id = id,     time = time,     outcome = bdi,     pre = 1,     post = 4,     m_functional = 7.69,     sd_functional = 7.52,     reliability = 0.801,     type = \"c\",     group = treatment   )  results_grouped #> Clinical Significance Results (JT) #>  #> Group | Category     |  n | Percent #> ----------------------------------- #> TAU   | Recovered    |  3 |   0.158 #> TAU   | Improved     |  2 |   0.105 #> TAU   | Unchanged    | 14 |   0.737 #> TAU   | Deteriorated |  0 |   0.000 #> TAU   | Harmed       |  0 |   0.000 #> PA    | Recovered    |  7 |   0.333 #> PA    | Improved     |  6 |   0.286 #> PA    | Unchanged    |  8 |   0.381 #> PA    | Deteriorated |  0 |   0.000 #> PA    | Harmed       |  0 |   0.000 plot(results_grouped, upper_limit = 63)"},{"path":"/articles/clinicalsignificance.html","id":"other-methods","dir":"Articles","previous_headings":"","what":"Other Methods","title":"Get started","text":"several proposed methods conduct clinical significance analysis packages contains . Available Jacobson & Truax (JT, Jacobson & Truax, 1991), default Gulliksen, Lord & Novick (GLN, Hsu, 1989, 1995) Hsu, Linn & Lord (HLL, Hsu, 1989) Edwards & Nunnally (EN, Speer, 1992) Nunnally & Kotsch (NK, Nunnally & Kotsch, 1983) Hageman & Arrindell (HA, Hageman & Arrindell, 1999) Hierarchical Linear Modeling (HLM, Raudenbush & Bryk, 2002) can easily applied via method argument, e.g., one can analyse data sophisticated complicated HA method (Hageman & Arrindell, 1999).","code":"results_ha <- claus_2020 %>%    clinical_significance(     id = id,     time = time,     outcome = bdi,      pre = 1,     post = 4,     m_functional = 7.69,     sd_functional = 7.52,     reliability = 0.801,     type = \"c\",     method = \"HA\"   )  results_ha #> Clinical Significance Results (HA Individual Level) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    |  8 |   0.200 #> Improved     | 17 |   0.425 #> Unchanged    | 15 |   0.375 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 #>  #> Clinical Significance Results (HA Group Level) #>  #> Category   | Percent #> -------------------- #> Changed    |   0.841 #> Functional |   0.353  plot(results_ha, upper_limit = 63)"},{"path":[]},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Benedikt Claus. Author, maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Claus B (2022). clinicalsignificance: Determine Clinical Significance Clinical Trials. R package version 1.0.0.","code":"@Manual{,   title = {clinicalsignificance: Determine the Clinical Significance in Clinical Trials},   author = {Benedikt Claus},   year = {2022},   note = {R package version 1.0.0}, }"},{"path":"/index.html","id":"clinicalsignificance-","dir":"","previous_headings":"","what":"An R-Package for Clinical Significance Analyses","title":"An R-Package for Clinical Significance Analyses","text":"goal package provide necessary tools analyses clinical significance clinical intervention studies. contrast statistical significance, assesses probable treatment effect, clinical significance can used determine treatment effect practical use meaningful patients.","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"An R-Package for Clinical Significance Analyses","text":"can install development version clinicalsignificance GitHub :","code":"# install.packages(\"devtools\") devtools::install_github(\"pedscience/clinicalsignificance\")"},{"path":"/index.html","id":"example","dir":"","previous_headings":"","what":"Example","title":"An R-Package for Clinical Significance Analyses","text":"Given tidy dataset, employed instrument’s reliability descriptives (M SD) functional population, clinical significance study can easily assessed. can receive detailed summary analysis plot results ","code":"library(clinicalsignificance)  results <- claus_2020 %>%    clinical_significance(     id = id,      time = time,      outcome = bdi,      pre = 1,      post = 4,      reliability = 0.81,      m_functional = 8,      sd_functional = 8,      type = \"c\"   )  results #> Clinical Significance Results (JT) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.250 #> Improved     |  9 |   0.225 #> Unchanged    | 21 |   0.525 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 summary(results) #>  #> Clinical Significance Results #>  #> There were 43 participants in the whole dataset of which 40 (93%) #> could be included in the analysis. #>  #> The JT method for calculating cutoffs and reliable change was chosen #> and the outcome variable was \"bdi\". #>  #> The cutoff type was \"c\" with a value of 21.6 based on the following #> population characteristics (with lower values representing a #> beneficial outcome): #>  #> Population Characteristics #>  #> M Clinical | SD Clinical | M Functional | SD Functional #> ------------------------------------------------------- #> 35.48      | 8.16        | 8            | 8             #>  #>  #> The instrument's reliability was set to 0.81  #>  #> Individual Level Results #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.250 #> Improved     |  9 |   0.225 #> Unchanged    | 21 |   0.525 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 plot(results)"},{"path":"/index.html","id":"rationale","dir":"","previous_headings":"","what":"Rationale","title":"An R-Package for Clinical Significance Analyses","text":"Jacobson et al. (1984) criticized, along researchers, vast majority research psychological intervention research based statistical significance testing. procedure comes two major disadvantages: first, treatment effects based groups lack information individual participants. Second, significance test lacks practical relevance. One can think hypothetical intervention expands life expectancy 1 day. enough participants incorporated significance test, one can virtually guarantee significant result although agree intervention lacks practical relevance. Therefore, Jacobson et al. (1984) postulated additional procedure categorizes patient based /individual change. patient (reliably) moves dysfunctional functional population, patient’s change clinically significant. case depicted figure . Let’s suppose instrument assessing depressive symptoms. clinical population patients major depression may score average M = 34 SD = 8 instrument. functional population (case sample people without major depression) may score average M = 8 SD = 8 instrument. now individual patient major depression scores 32 depression instrument intervention (black point clinical population) 12 intervention (black point functional population) therefore crossed cutoff two populations (black line ), patient changed clinically significant (change beyond error measurement instrument).","code":""},{"path":[]},{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"GNU General Public License","title":"GNU General Public License","text":"Version 3, 29 June 2007Copyright © 2007 Free Software Foundation, Inc. <http://fsf.org/> Everyone permitted copy distribute verbatim copies license document, changing allowed.","code":""},{"path":"/LICENSE.html","id":"preamble","dir":"","previous_headings":"","what":"Preamble","title":"GNU General Public License","text":"GNU General Public License free, copyleft license software kinds works. licenses software practical works designed take away freedom share change works. contrast, GNU General Public License intended guarantee freedom share change versions program–make sure remains free software users. , Free Software Foundation, use GNU General Public License software; applies also work released way authors. can apply programs, . speak free software, referring freedom, price. General Public Licenses designed make sure freedom distribute copies free software (charge wish), receive source code can get want , can change software use pieces new free programs, know can things. protect rights, need prevent others denying rights asking surrender rights. Therefore, certain responsibilities distribute copies software, modify : responsibilities respect freedom others. example, distribute copies program, whether gratis fee, must pass recipients freedoms received. must make sure , , receive can get source code. must show terms know rights. Developers use GNU GPL protect rights two steps: (1) assert copyright software, (2) offer License giving legal permission copy, distribute /modify . developers’ authors’ protection, GPL clearly explains warranty free software. users’ authors’ sake, GPL requires modified versions marked changed, problems attributed erroneously authors previous versions. devices designed deny users access install run modified versions software inside , although manufacturer can . fundamentally incompatible aim protecting users’ freedom change software. systematic pattern abuse occurs area products individuals use, precisely unacceptable. Therefore, designed version GPL prohibit practice products. problems arise substantially domains, stand ready extend provision domains future versions GPL, needed protect freedom users. Finally, every program threatened constantly software patents. States allow patents restrict development use software general-purpose computers, , wish avoid special danger patents applied free program make effectively proprietary. prevent , GPL assures patents used render program non-free. precise terms conditions copying, distribution modification follow.","code":""},{"path":[]},{"path":"/LICENSE.html","id":"id_0-definitions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"0. Definitions","title":"GNU General Public License","text":"“License” refers version 3 GNU General Public License. “Copyright” also means copyright-like laws apply kinds works, semiconductor masks. “Program” refers copyrightable work licensed License. licensee addressed “”. “Licensees” “recipients” may individuals organizations. “modify” work means copy adapt part work fashion requiring copyright permission, making exact copy. resulting work called “modified version” earlier work work “based ” earlier work. “covered work” means either unmodified Program work based Program. “propagate” work means anything , without permission, make directly secondarily liable infringement applicable copyright law, except executing computer modifying private copy. Propagation includes copying, distribution (without modification), making available public, countries activities well. “convey” work means kind propagation enables parties make receive copies. Mere interaction user computer network, transfer copy, conveying. interactive user interface displays “Appropriate Legal Notices” extent includes convenient prominently visible feature (1) displays appropriate copyright notice, (2) tells user warranty work (except extent warranties provided), licensees may convey work License, view copy License. interface presents list user commands options, menu, prominent item list meets criterion.","code":""},{"path":"/LICENSE.html","id":"id_1-source-code","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"1. Source Code","title":"GNU General Public License","text":"“source code” work means preferred form work making modifications . “Object code” means non-source form work. “Standard Interface” means interface either official standard defined recognized standards body, , case interfaces specified particular programming language, one widely used among developers working language. “System Libraries” executable work include anything, work whole, () included normal form packaging Major Component, part Major Component, (b) serves enable use work Major Component, implement Standard Interface implementation available public source code form. “Major Component”, context, means major essential component (kernel, window system, ) specific operating system () executable work runs, compiler used produce work, object code interpreter used run . “Corresponding Source” work object code form means source code needed generate, install, (executable work) run object code modify work, including scripts control activities. However, include work’s System Libraries, general-purpose tools generally available free programs used unmodified performing activities part work. example, Corresponding Source includes interface definition files associated source files work, source code shared libraries dynamically linked subprograms work specifically designed require, intimate data communication control flow subprograms parts work. Corresponding Source need include anything users can regenerate automatically parts Corresponding Source. Corresponding Source work source code form work.","code":""},{"path":"/LICENSE.html","id":"id_2-basic-permissions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"2. Basic Permissions","title":"GNU General Public License","text":"rights granted License granted term copyright Program, irrevocable provided stated conditions met. License explicitly affirms unlimited permission run unmodified Program. output running covered work covered License output, given content, constitutes covered work. License acknowledges rights fair use equivalent, provided copyright law. may make, run propagate covered works convey, without conditions long license otherwise remains force. may convey covered works others sole purpose make modifications exclusively , provide facilities running works, provided comply terms License conveying material control copyright. thus making running covered works must exclusively behalf, direction control, terms prohibit making copies copyrighted material outside relationship . Conveying circumstances permitted solely conditions stated . Sublicensing allowed; section 10 makes unnecessary.","code":""},{"path":"/LICENSE.html","id":"id_3-protecting-users-legal-rights-from-anti-circumvention-law","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"3. Protecting Users’ Legal Rights From Anti-Circumvention Law","title":"GNU General Public License","text":"covered work shall deemed part effective technological measure applicable law fulfilling obligations article 11 WIPO copyright treaty adopted 20 December 1996, similar laws prohibiting restricting circumvention measures. convey covered work, waive legal power forbid circumvention technological measures extent circumvention effected exercising rights License respect covered work, disclaim intention limit operation modification work means enforcing, work’s users, third parties’ legal rights forbid circumvention technological measures.","code":""},{"path":"/LICENSE.html","id":"id_4-conveying-verbatim-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"4. Conveying Verbatim Copies","title":"GNU General Public License","text":"may convey verbatim copies Program’s source code receive , medium, provided conspicuously appropriately publish copy appropriate copyright notice; keep intact notices stating License non-permissive terms added accord section 7 apply code; keep intact notices absence warranty; give recipients copy License along Program. may charge price price copy convey, may offer support warranty protection fee.","code":""},{"path":"/LICENSE.html","id":"id_5-conveying-modified-source-versions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"5. Conveying Modified Source Versions","title":"GNU General Public License","text":"may convey work based Program, modifications produce Program, form source code terms section 4, provided also meet conditions: ) work must carry prominent notices stating modified , giving relevant date. b) work must carry prominent notices stating released License conditions added section 7. requirement modifies requirement section 4 “keep intact notices”. c) must license entire work, whole, License anyone comes possession copy. License therefore apply, along applicable section 7 additional terms, whole work, parts, regardless packaged. License gives permission license work way, invalidate permission separately received . d) work interactive user interfaces, must display Appropriate Legal Notices; however, Program interactive interfaces display Appropriate Legal Notices, work need make . compilation covered work separate independent works, nature extensions covered work, combined form larger program, volume storage distribution medium, called “aggregate” compilation resulting copyright used limit access legal rights compilation’s users beyond individual works permit. Inclusion covered work aggregate cause License apply parts aggregate.","code":""},{"path":"/LICENSE.html","id":"id_6-conveying-non-source-forms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"6. Conveying Non-Source Forms","title":"GNU General Public License","text":"may convey covered work object code form terms sections 4 5, provided also convey machine-readable Corresponding Source terms License, one ways: ) Convey object code , embodied , physical product (including physical distribution medium), accompanied Corresponding Source fixed durable physical medium customarily used software interchange. b) Convey object code , embodied , physical product (including physical distribution medium), accompanied written offer, valid least three years valid long offer spare parts customer support product model, give anyone possesses object code either (1) copy Corresponding Source software product covered License, durable physical medium customarily used software interchange, price reasonable cost physically performing conveying source, (2) access copy Corresponding Source network server charge. c) Convey individual copies object code copy written offer provide Corresponding Source. alternative allowed occasionally noncommercially, received object code offer, accord subsection 6b. d) Convey object code offering access designated place (gratis charge), offer equivalent access Corresponding Source way place charge. need require recipients copy Corresponding Source along object code. place copy object code network server, Corresponding Source may different server (operated third party) supports equivalent copying facilities, provided maintain clear directions next object code saying find Corresponding Source. Regardless server hosts Corresponding Source, remain obligated ensure available long needed satisfy requirements. e) Convey object code using peer--peer transmission, provided inform peers object code Corresponding Source work offered general public charge subsection 6d. separable portion object code, whose source code excluded Corresponding Source System Library, need included conveying object code work. “User Product” either (1) “consumer product”, means tangible personal property normally used personal, family, household purposes, (2) anything designed sold incorporation dwelling. determining whether product consumer product, doubtful cases shall resolved favor coverage. particular product received particular user, “normally used” refers typical common use class product, regardless status particular user way particular user actually uses, expects expected use, product. product consumer product regardless whether product substantial commercial, industrial non-consumer uses, unless uses represent significant mode use product. “Installation Information” User Product means methods, procedures, authorization keys, information required install execute modified versions covered work User Product modified version Corresponding Source. information must suffice ensure continued functioning modified object code case prevented interfered solely modification made. convey object code work section , , specifically use , User Product, conveying occurs part transaction right possession use User Product transferred recipient perpetuity fixed term (regardless transaction characterized), Corresponding Source conveyed section must accompanied Installation Information. requirement apply neither third party retains ability install modified object code User Product (example, work installed ROM). requirement provide Installation Information include requirement continue provide support service, warranty, updates work modified installed recipient, User Product modified installed. Access network may denied modification materially adversely affects operation network violates rules protocols communication across network. Corresponding Source conveyed, Installation Information provided, accord section must format publicly documented (implementation available public source code form), must require special password key unpacking, reading copying.","code":""},{"path":"/LICENSE.html","id":"id_7-additional-terms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"7. Additional Terms","title":"GNU General Public License","text":"“Additional permissions” terms supplement terms License making exceptions one conditions. Additional permissions applicable entire Program shall treated though included License, extent valid applicable law. additional permissions apply part Program, part may used separately permissions, entire Program remains governed License without regard additional permissions. convey copy covered work, may option remove additional permissions copy, part . (Additional permissions may written require removal certain cases modify work.) may place additional permissions material, added covered work, can give appropriate copyright permission. Notwithstanding provision License, material add covered work, may (authorized copyright holders material) supplement terms License terms: ) Disclaiming warranty limiting liability differently terms sections 15 16 License; b) Requiring preservation specified reasonable legal notices author attributions material Appropriate Legal Notices displayed works containing ; c) Prohibiting misrepresentation origin material, requiring modified versions material marked reasonable ways different original version; d) Limiting use publicity purposes names licensors authors material; e) Declining grant rights trademark law use trade names, trademarks, service marks; f) Requiring indemnification licensors authors material anyone conveys material (modified versions ) contractual assumptions liability recipient, liability contractual assumptions directly impose licensors authors. non-permissive additional terms considered “restrictions” within meaning section 10. Program received , part , contains notice stating governed License along term restriction, may remove term. license document contains restriction permits relicensing conveying License, may add covered work material governed terms license document, provided restriction survive relicensing conveying. add terms covered work accord section, must place, relevant source files, statement additional terms apply files, notice indicating find applicable terms. Additional terms, permissive non-permissive, may stated form separately written license, stated exceptions; requirements apply either way.","code":""},{"path":"/LICENSE.html","id":"id_8-termination","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"8. Termination","title":"GNU General Public License","text":"may propagate modify covered work except expressly provided License. attempt otherwise propagate modify void, automatically terminate rights License (including patent licenses granted third paragraph section 11). However, cease violation License, license particular copyright holder reinstated () provisionally, unless copyright holder explicitly finally terminates license, (b) permanently, copyright holder fails notify violation reasonable means prior 60 days cessation. Moreover, license particular copyright holder reinstated permanently copyright holder notifies violation reasonable means, first time received notice violation License (work) copyright holder, cure violation prior 30 days receipt notice. Termination rights section terminate licenses parties received copies rights License. rights terminated permanently reinstated, qualify receive new licenses material section 10.","code":""},{"path":"/LICENSE.html","id":"id_9-acceptance-not-required-for-having-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"9. Acceptance Not Required for Having Copies","title":"GNU General Public License","text":"required accept License order receive run copy Program. Ancillary propagation covered work occurring solely consequence using peer--peer transmission receive copy likewise require acceptance. However, nothing License grants permission propagate modify covered work. actions infringe copyright accept License. Therefore, modifying propagating covered work, indicate acceptance License .","code":""},{"path":"/LICENSE.html","id":"id_10-automatic-licensing-of-downstream-recipients","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"10. Automatic Licensing of Downstream Recipients","title":"GNU General Public License","text":"time convey covered work, recipient automatically receives license original licensors, run, modify propagate work, subject License. responsible enforcing compliance third parties License. “entity transaction” transaction transferring control organization, substantially assets one, subdividing organization, merging organizations. propagation covered work results entity transaction, party transaction receives copy work also receives whatever licenses work party’s predecessor interest give previous paragraph, plus right possession Corresponding Source work predecessor interest, predecessor can get reasonable efforts. may impose restrictions exercise rights granted affirmed License. example, may impose license fee, royalty, charge exercise rights granted License, may initiate litigation (including cross-claim counterclaim lawsuit) alleging patent claim infringed making, using, selling, offering sale, importing Program portion .","code":""},{"path":"/LICENSE.html","id":"id_11-patents","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"11. Patents","title":"GNU General Public License","text":"“contributor” copyright holder authorizes use License Program work Program based. work thus licensed called contributor’s “contributor version”. contributor’s “essential patent claims” patent claims owned controlled contributor, whether already acquired hereafter acquired, infringed manner, permitted License, making, using, selling contributor version, include claims infringed consequence modification contributor version. purposes definition, “control” includes right grant patent sublicenses manner consistent requirements License. contributor grants non-exclusive, worldwide, royalty-free patent license contributor’s essential patent claims, make, use, sell, offer sale, import otherwise run, modify propagate contents contributor version. following three paragraphs, “patent license” express agreement commitment, however denominated, enforce patent (express permission practice patent covenant sue patent infringement). “grant” patent license party means make agreement commitment enforce patent party. convey covered work, knowingly relying patent license, Corresponding Source work available anyone copy, free charge terms License, publicly available network server readily accessible means, must either (1) cause Corresponding Source available, (2) arrange deprive benefit patent license particular work, (3) arrange, manner consistent requirements License, extend patent license downstream recipients. “Knowingly relying” means actual knowledge , patent license, conveying covered work country, recipient’s use covered work country, infringe one identifiable patents country reason believe valid. , pursuant connection single transaction arrangement, convey, propagate procuring conveyance , covered work, grant patent license parties receiving covered work authorizing use, propagate, modify convey specific copy covered work, patent license grant automatically extended recipients covered work works based . patent license “discriminatory” include within scope coverage, prohibits exercise , conditioned non-exercise one rights specifically granted License. may convey covered work party arrangement third party business distributing software, make payment third party based extent activity conveying work, third party grants, parties receive covered work , discriminatory patent license () connection copies covered work conveyed (copies made copies), (b) primarily connection specific products compilations contain covered work, unless entered arrangement, patent license granted, prior 28 March 2007. Nothing License shall construed excluding limiting implied license defenses infringement may otherwise available applicable patent law.","code":""},{"path":"/LICENSE.html","id":"id_12-no-surrender-of-others-freedom","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"12. No Surrender of Others’ Freedom","title":"GNU General Public License","text":"conditions imposed (whether court order, agreement otherwise) contradict conditions License, excuse conditions License. convey covered work satisfy simultaneously obligations License pertinent obligations, consequence may convey . example, agree terms obligate collect royalty conveying convey Program, way satisfy terms License refrain entirely conveying Program.","code":""},{"path":"/LICENSE.html","id":"id_13-use-with-the-gnu-affero-general-public-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"13. Use with the GNU Affero General Public License","title":"GNU General Public License","text":"Notwithstanding provision License, permission link combine covered work work licensed version 3 GNU Affero General Public License single combined work, convey resulting work. terms License continue apply part covered work, special requirements GNU Affero General Public License, section 13, concerning interaction network apply combination .","code":""},{"path":"/LICENSE.html","id":"id_14-revised-versions-of-this-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"14. Revised Versions of this License","title":"GNU General Public License","text":"Free Software Foundation may publish revised /new versions GNU General Public License time time. new versions similar spirit present version, may differ detail address new problems concerns. version given distinguishing version number. Program specifies certain numbered version GNU General Public License “later version” applies , option following terms conditions either numbered version later version published Free Software Foundation. Program specify version number GNU General Public License, may choose version ever published Free Software Foundation. Program specifies proxy can decide future versions GNU General Public License can used, proxy’s public statement acceptance version permanently authorizes choose version Program. Later license versions may give additional different permissions. However, additional obligations imposed author copyright holder result choosing follow later version.","code":""},{"path":"/LICENSE.html","id":"id_15-disclaimer-of-warranty","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"15. Disclaimer of Warranty","title":"GNU General Public License","text":"WARRANTY PROGRAM, EXTENT PERMITTED APPLICABLE LAW. EXCEPT OTHERWISE STATED WRITING COPYRIGHT HOLDERS /PARTIES PROVIDE PROGRAM “” WITHOUT WARRANTY KIND, EITHER EXPRESSED IMPLIED, INCLUDING, LIMITED , IMPLIED WARRANTIES MERCHANTABILITY FITNESS PARTICULAR PURPOSE. ENTIRE RISK QUALITY PERFORMANCE PROGRAM . PROGRAM PROVE DEFECTIVE, ASSUME COST NECESSARY SERVICING, REPAIR CORRECTION.","code":""},{"path":"/LICENSE.html","id":"id_16-limitation-of-liability","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"16. Limitation of Liability","title":"GNU General Public License","text":"EVENT UNLESS REQUIRED APPLICABLE LAW AGREED WRITING COPYRIGHT HOLDER, PARTY MODIFIES /CONVEYS PROGRAM PERMITTED , LIABLE DAMAGES, INCLUDING GENERAL, SPECIAL, INCIDENTAL CONSEQUENTIAL DAMAGES ARISING USE INABILITY USE PROGRAM (INCLUDING LIMITED LOSS DATA DATA RENDERED INACCURATE LOSSES SUSTAINED THIRD PARTIES FAILURE PROGRAM OPERATE PROGRAMS), EVEN HOLDER PARTY ADVISED POSSIBILITY DAMAGES.","code":""},{"path":"/LICENSE.html","id":"id_17-interpretation-of-sections-15-and-16","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"17. Interpretation of Sections 15 and 16","title":"GNU General Public License","text":"disclaimer warranty limitation liability provided given local legal effect according terms, reviewing courts shall apply local law closely approximates absolute waiver civil liability connection Program, unless warranty assumption liability accompanies copy Program return fee. END TERMS CONDITIONS","code":""},{"path":"/LICENSE.html","id":"how-to-apply-these-terms-to-your-new-programs","dir":"","previous_headings":"","what":"How to Apply These Terms to Your New Programs","title":"GNU General Public License","text":"develop new program, want greatest possible use public, best way achieve make free software everyone can redistribute change terms. , attach following notices program. safest attach start source file effectively state exclusion warranty; file least “copyright” line pointer full notice found. Also add information contact electronic paper mail. program terminal interaction, make output short notice like starts interactive mode: hypothetical commands show w show c show appropriate parts General Public License. course, program’s commands might different; GUI interface, use “box”. also get employer (work programmer) school, , sign “copyright disclaimer” program, necessary. information , apply follow GNU GPL, see <http://www.gnu.org/licenses/>. GNU General Public License permit incorporating program proprietary programs. program subroutine library, may consider useful permit linking proprietary applications library. want , use GNU Lesser General Public License instead License. first, please read <http://www.gnu.org/philosophy/--lgpl.html>.","code":"<one line to give the program's name and a brief idea of what it does.> Copyright (C) <year>  <name of author>  This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version.  This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU General Public License for more details.  You should have received a copy of the GNU General Public License along with this program.  If not, see <http://www.gnu.org/licenses/>. <program>  Copyright (C) <year>  <name of author> This program comes with ABSOLUTELY NO WARRANTY; for details type 'show w'. This is free software, and you are welcome to redistribute it under certain conditions; type 'show c' for details."},{"path":"/reference/anxiety.html","id":null,"dir":"Reference","previous_headings":"","what":"Anxiety Data — anxiety","title":"Anxiety Data — anxiety","text":"fictional dataset missings exemplify use HLM method clinical significance.","code":""},{"path":"/reference/anxiety.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Anxiety Data — anxiety","text":"","code":"anxiety"},{"path":"/reference/anxiety.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Anxiety Data — anxiety","text":"data frame 580 rows 4 variables: subject Participant treatment Treatment. Either Placebo Intervention. measurement Number measurement anxiety Anxiety score, lower better.","code":""},{"path":"/reference/anxiety.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Anxiety Data — anxiety","text":"fictional clinical trial, participants split belong either medical placebo (\"Placebo\") psychotherapeutic intervention (\"Intervention\") group. underwent outpatient treatment followed 5 measurements fictional anxiety score measured. anxiety score may range 0 - 60. functional population (.e., non-anxious individuals) can expected mean score M = 8 points standard deviation SD = 4.","code":""},{"path":"/reference/anxiety_complete.html","id":null,"dir":"Reference","previous_headings":"","what":"Anxiety Data (Complete) — anxiety_complete","title":"Anxiety Data (Complete) — anxiety_complete","text":"fictional complete dataset exemplify use HLM method clinical significance.","code":""},{"path":"/reference/anxiety_complete.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Anxiety Data (Complete) — anxiety_complete","text":"","code":"anxiety_complete"},{"path":"/reference/anxiety_complete.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Anxiety Data (Complete) — anxiety_complete","text":"data frame 580 rows 4 variables: subject Participant treatment Treatment. Either Placebo Intervention. measurement Number measurement anxiety Anxiety score, lower better.","code":""},{"path":"/reference/anxiety_complete.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Anxiety Data (Complete) — anxiety_complete","text":"fictional clinical trial, participants split belong either medical placebo (\"Placebo\") psychotherapeutic intervention (\"Intervention\") group. underwent outpatient treatment followed 5 measurements fictional anxiety score measured. anxiety score may range 0 - 60. functional population (.e., non-anxious individuals) can expected mean score M = 8 points standard deviation SD = 4.","code":""},{"path":"/reference/check_cutoff.html","id":null,"dir":"Reference","previous_headings":"","what":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","title":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","text":"Check Clinical Significance Cutoff Based Population Descriptives","code":""},{"path":"/reference/check_cutoff.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","text":"","code":"check_cutoff(   object = NULL,   m_clinical,   sd_clinical,   m_functional = NA,   sd_functional = NA,   type = c(\"a\", \"b\", \"c\"),   better_is = c(\"lower\", \"higher\"),   resolution = 300 )"},{"path":"/reference/check_cutoff.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","text":"object object class clinisig. optional can used visualize cutoffs conducting clinical significance analysis. m_clinical Mean clinical population sd_clinical SD clinical population m_functional M functional population sd_functional SD functional population type Cutoff type. Available \"\", \"b\", \"c\". Defaults \"\" (see details information cutoff choose) better_is direction means better outcome employed outcome? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) resolution Curve resolution (number points drawn). may improve smoothness highly peaked curves.","code":""},{"path":"/reference/check_cutoff.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","text":"ggplot2","code":""},{"path":"/reference/check_cutoff.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Check the Clinical Significance Cutoff Based on Population Descriptives — check_cutoff","text":"","code":"# Check cutoff with manually specified values check_cutoff(m_clinical = 40, sd_clinical = 12, m_functional = 10, sd_functional = 12)    # Or check the cutoff after you conducted a clinical significance analysis results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 7,     type = \"c\"   )  check_cutoff(results)"},{"path":"/reference/claus_2020.html","id":null,"dir":"Reference","previous_headings":"","what":"Placebo Amplification Data — claus_2020","title":"Placebo Amplification Data — claus_2020","text":"dataset containing data Claus et al. (2020). routine inpatient setting unipolar depressive disorders implemented intervention sought amplify placebo response antidepressants. study, two groups compared: treatment usual (TAU) placebo amplification (PA). Participants examined four times treatment.","code":""},{"path":"/reference/claus_2020.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Placebo Amplification Data — claus_2020","text":"","code":"claus_2020"},{"path":"/reference/claus_2020.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Placebo Amplification Data — claus_2020","text":"object class tbl_df 172 rows 9 columns. id Participant ID age Age sex Sex treatment Treatment (TAU treatment usual PA placebo amplification) time Measurement bdi Beck Depression Inventory (2nd Edition) score shaps Snaith-Hamilton Pleasure Scale score -Five Well-Index score hamd Hamilton Rating Scale Depression score","code":""},{"path":"/reference/claus_2020.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Placebo Amplification Data — claus_2020","text":"https://osf.io/rc754/","code":""},{"path":"/reference/claus_2020.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Placebo Amplification Data — claus_2020","text":"Claus, B. B., Scherbaum, N., & Bonnet, U. (2020). Effectiveness Adjunctive Psychotherapeutic Intervention Developed Enhancing Placebo Effect Antidepressants Used within Inpatient-Treatment Program Major Depression: Pragmatic Parallel-Group, Randomized Controlled Trial. Psychotherapy Psychosomatics, 89(4), 258-260. https://doi.org/10.1159/000505855","code":""},{"path":"/reference/clinical_significance.html","id":null,"dir":"Reference","previous_headings":"","what":"Clinical Significance — clinical_significance","title":"Clinical Significance — clinical_significance","text":"function conducts clinical significance analysis determining patients changed reliably moved clinical functional population study.","code":""},{"path":"/reference/clinical_significance.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Clinical Significance — clinical_significance","text":"","code":"clinical_significance(   data,   id,   time,   outcome,   group = NULL,   pre = NULL,   post = NULL,   m_functional = NA,   sd_functional = NA,   type = \"a\",   reliability,   reliability_post,   better_is = c(\"lower\", \"higher\"),   method = c(\"JT\", \"GLN\", \"HLL\", \"EN\", \"NK\", \"HA\", \"HLM\") )"},{"path":"/reference/clinical_significance.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Clinical Significance — clinical_significance","text":"data tidy data frame id Participant ID time Time variable outcome Outcome variable group Grouping variable pre Pre measurement post Post measurement m_functional Mean functional population sd_functional Standard deviation functional population type Cutoff type. Available \"\", \"b\", \"c\". Defaults \"\" (see details information cutoff choose) reliability instrument's reliability estimate. selected NK method, specified reliability instrument's pre measurement reliability reliability_post instrument's reliability post measurement. relevant NK method better_is direction means better outcome employed outcome? Available \"lower\" (lower outcome scores desirable, default) \"higher\" (higher outcome scores desirable) method Clinical significance method. Available \"JT\" (Jacobson & Truax, 1991, default) \"GLN\" (Gulliksen, Lord, Novick; Hsu, 1989, Hsu, 1995) \"HLL\" (Hsu, Linn & Nord; Hsu, 1989) \"EN\" (Edwards & Nunnally; Speer, 1992) \"NK\" (Nunnally & Kotsch, 1983), requires reliability estimate post measurement. supplied, reliability reliability_post assumed equal \"HA\" (Hageman & Arrindell, 1999) \"HLM\" (Hierarchical Linear Modeling; Raudenbush & Bryk, 2002), requires least three measurements per patient","code":""},{"path":"/reference/clinical_significance.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Clinical Significance — clinical_significance","text":"S3 object class clinisig","code":""},{"path":"/reference/clinical_significance.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Clinical Significance — clinical_significance","text":"default, JT method used, methods implemented (see description arguments). generally recommended use cutoff \"c\", thus, incorporating information clinical functional population cutoff calculation.","code":""},{"path":"/reference/clinical_significance.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Clinical Significance — clinical_significance","text":"Jacobson, N. S., & Truax, P. (1991). Clinical significance: statistical approach defining meaningful change psychotherapy research. Journal Consulting Clinical Psychology, 59(1), 12–19. https://doi.org/10.1037//0022-006X.59.1.12 Hsu, L. M. (1989). Reliable changes psychotherapy: Taking account regression toward mean. Behavioral Assessment, 11(4), 459–467. Hsu, L. M. (1995). Regression toward mean associated measurement error identification improvement deterioration psychotherapy. Journal Consulting Clinical Psychology, 63(1), 141–144. https://doi.org/10.1037//0022-006x.63.1.141 Speer, D. C. (1992). Clinically significant change: Jacobson Truax (1991) revisited. Journal Consulting Clinical Psychology, 60(3), 402–408. https://doi.org/10.1037/0022-006X.60.3.402 Nunnally, J. C., & Kotsch, W. E. (1983). Studies individual subjects: Logic methods analysis. British Journal Clinical Psychology, 22(2), 83–93. https://doi.org/10.1111/j.2044-8260.1983.tb00582.x Hageman, W. J., & Arrindell, W. . (1999). Establishing clinically significant change: increment precision distinction individual group level analysis. Behaviour Research Therapy, 37(12), 1169–1193. https://doi.org/10.1016/S0005-7967(99)00032-7 Raudenbush, S. W., & Bryk, . S. (2002). Hierarchical Linear Models - Applications Data Analysis Methods (2nd ed.). Sage Publications.","code":""},{"path":"/reference/clinical_significance.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Clinical Significance — clinical_significance","text":"","code":"# Clinical significane for \"negative\" outcomes (lower values are desirable) jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80   ) #> Clinical Significance Results (JT) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.385 #> Improved     |  4 |   0.154 #> Unchanged    | 12 |   0.462 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000   # Clinical significane for \"positive\" outcomes (higher values are desirable) jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = das,     pre = \"pre\",     reliability = 0.80,     better_is = \"higher\"   ) #> Clinical Significance Results (JT) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    | 10 |   0.333 #> Improved     |  6 |   0.200 #> Unchanged    | 13 |   0.433 #> Deteriorated |  1 |   0.033 #> Harmed       |  0 |   0.000   # Clinical significance incorporating descriptives of a functional population. # Make sure to select type = \"c\" to incorporate the specified functional # descriptives. jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 7,     type = \"c\"   ) #> Clinical Significance Results (JT) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    |  3 |   0.115 #> Improved     | 11 |   0.423 #> Unchanged    | 12 |   0.462 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000   # Change the clinical significance method jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 7,     type = \"c\",     method = \"EN\"   ) #> Clinical Significance Results (EN) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    |  4 |   0.154 #> Improved     | 13 |   0.500 #> Unchanged    |  9 |   0.346 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000  jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 7,     type = \"c\",     method = \"HA\"   ) #> Clinical Significance Results (HA Individual Level) #>  #> Category     |  n | Percent #> --------------------------- #> Recovered    |  1 |   0.038 #> Improved     | 16 |   0.615 #> Unchanged    |  9 |   0.346 #> Deteriorated |  0 |   0.000 #> Harmed       |  0 |   0.000 #>  #> Clinical Significance Results (HA Group Level) #>  #> Category   | Percent #> -------------------- #> Changed    |   0.900 #> Functional |   0.163   # And plot your results results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 7,     type = \"c\"   )  plot(results)"},{"path":"/reference/get_augmented_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","title":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","text":"Get Data Augmented Clinical Significance Categories","code":""},{"path":"/reference/get_augmented_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","text":"","code":"get_augmented_data(x)"},{"path":"/reference/get_augmented_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","text":"x clinisig object.","code":""},{"path":"/reference/get_augmented_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","text":"tibble used data clinical significance categories","code":""},{"path":"/reference/get_augmented_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Data Augmented With Clinical Significance Categories — get_augmented_data","text":"","code":"results <- jacobson_1989 %>% clinical_significance(   id = subject,   time = time,   outcome = gds,   pre = \"pre\",   reliability = 0.80,   m_functional = 30,   sd_functional = 7,   type = \"c\" )  get_augmented_data(results) #> # A tibble: 26 × 13 #>       id   pre  post change    rci clinical_pre functional_post recovered #>    <dbl> <dbl> <dbl>  <dbl>  <dbl> <lgl>        <lgl>           <lgl>     #>  1     1  68    62.5   -5.5 -1.43  TRUE         FALSE           FALSE     #>  2     2  74.5  56    -18.5 -4.79  TRUE         FALSE           FALSE     #>  3     3  58.5  58     -0.5 -0.130 TRUE         FALSE           FALSE     #>  4     4  73.5  71     -2.5 -0.648 TRUE         FALSE           FALSE     #>  5     5  78.5  60.5  -18   -4.66  TRUE         FALSE           FALSE     #>  6     6  76    77      1    0.259 TRUE         FALSE           FALSE     #>  7     7  76.5  58.5  -18   -4.66  TRUE         FALSE           FALSE     #>  8     8  63    52    -11   -2.85  TRUE         FALSE           FALSE     #>  9     9  70    65.5   -4.5 -1.17  TRUE         FALSE           FALSE     #> 10    10  75    73     -2   -0.518 TRUE         FALSE           FALSE     #> # … with 16 more rows, and 5 more variables: improved <lgl>, unchanged <lgl>, #> #   deteriorated <lgl>, harmed <lgl>, category <fct>"},{"path":"/reference/get_beneficial_direction.html","id":null,"dir":"Reference","previous_headings":"","what":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","title":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","text":"Get Specified Beneficial Direction Clinical Significance Analysis","code":""},{"path":"/reference/get_beneficial_direction.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","text":"","code":"get_beneficial_direction(x, ...)"},{"path":"/reference/get_beneficial_direction.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","text":"x clinisig object ... Additional arguments","code":""},{"path":"/reference/get_beneficial_direction.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","text":"string","code":""},{"path":"/reference/get_beneficial_direction.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get the Specified Beneficial Direction of a Clinical Significance Analysis — get_beneficial_direction","text":"","code":"results <- jacobson_1989 %>% clinical_significance(   id = subject,   time = time,   outcome = gds,   pre = \"pre\",   reliability = 0.80 )  get_beneficial_direction(results) #> [1] \"lower\""},{"path":"/reference/get_cutoff.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","title":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","text":"Get Used Cutoff Type clinisig Object","code":""},{"path":"/reference/get_cutoff.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","text":"","code":"get_cutoff(x, with_descriptives = FALSE)"},{"path":"/reference/get_cutoff.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","text":"x clinisig object with_descriptives Logical indicating whether want retrieve cutoff type value summary statistics based . default FALSE.","code":""},{"path":"/reference/get_cutoff.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","text":"tibble cutoff information","code":""},{"path":"/reference/get_cutoff.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Used Cutoff And Type From A clinisig Object — get_cutoff","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  get_cutoff(results) #> # A tibble: 1 × 2 #>   type  value #>   <chr> <dbl> #> 1 c      54.3"},{"path":"/reference/get_cutoff_descriptives.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","title":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","text":"Get Descriptives Used Cutoff Calculation","code":""},{"path":"/reference/get_cutoff_descriptives.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","text":"","code":"get_cutoff_descriptives(x)"},{"path":"/reference/get_cutoff_descriptives.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","text":"x clinisig object","code":""},{"path":"/reference/get_cutoff_descriptives.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","text":"tibble means standard deviations clinical functional population","code":""},{"path":"/reference/get_cutoff_descriptives.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Descriptives Used In The Cutoff Calculation — get_cutoff_descriptives","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  get_cutoff_descriptives(results) #> # A tibble: 1 × 4 #>   m_clinical sd_clinical m_functional sd_functional #>        <dbl>       <dbl>        <dbl>         <dbl> #> 1       69.2        6.10           30            10"},{"path":"/reference/get_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Data From A clinisig Object — get_data","title":"Get Data From A clinisig Object — get_data","text":"Get Data clinisig Object","code":""},{"path":"/reference/get_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Data From A clinisig Object — get_data","text":"","code":"get_data(x, dataset = \"data\")"},{"path":"/reference/get_data.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Data From A clinisig Object — get_data","text":"x clinisig object. dataset dataset wish retrieve. Available options \"original\" (raw original dataset) \"wide\" (original dataset wide format) \"data\" (dataset used calculations). default \"data\"","code":""},{"path":"/reference/get_data.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Data From A clinisig Object — get_data","text":"tibble","code":""},{"path":"/reference/get_data.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Data From A clinisig Object — get_data","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  get_data(results) #> # A tibble: 26 × 4 #>       id   pre  post change #>    <dbl> <dbl> <dbl>  <dbl> #>  1     1  68    62.5   -5.5 #>  2     2  74.5  56    -18.5 #>  3     3  58.5  58     -0.5 #>  4     4  73.5  71     -2.5 #>  5     5  78.5  60.5  -18   #>  6     6  76    77      1   #>  7     7  76.5  58.5  -18   #>  8     8  63    52    -11   #>  9     9  70    65.5   -4.5 #> 10    10  75    73     -2   #> # … with 16 more rows get_data(results, \"wide\") #> # A tibble: 30 × 3 #>       id   pre  post #>    <dbl> <dbl> <dbl> #>  1     1  68    62.5 #>  2     2  74.5  56   #>  3     3  58.5  58   #>  4     4  73.5  71   #>  5     5  78.5  60.5 #>  6     6  76    77   #>  7     7  76.5  58.5 #>  8     8  63    52   #>  9     9  70    65.5 #> 10    10  75    73   #> # … with 20 more rows get_data(results, \"original\") #> # A tibble: 60 × 4 #>    subject time    das   gds #>      <dbl> <chr> <dbl> <dbl> #>  1       1 pre    90.5  68   #>  2       1 post   97    62.5 #>  3       2 pre    74    74.5 #>  4       2 post  124    56   #>  5       3 pre    97    58.5 #>  6       3 post   97.5  58   #>  7       4 pre    73.5  73.5 #>  8       4 post   88    71   #>  9       5 pre    61    78.5 #> 10       5 post   96.5  60.5 #> # … with 50 more rows"},{"path":"/reference/get_method.html","id":null,"dir":"Reference","previous_headings":"","what":"Get the employed clinical significance method — get_method","title":"Get the employed clinical significance method — get_method","text":"may choose several methods conduct clinical significance analyses. function can retrieve employed method clinisig object.","code":""},{"path":"/reference/get_method.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get the employed clinical significance method — get_method","text":"","code":"get_method(x)"},{"path":"/reference/get_method.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get the employed clinical significance method — get_method","text":"x clinisig object","code":""},{"path":"/reference/get_method.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get the employed clinical significance method — get_method","text":"string","code":""},{"path":"/reference/get_method.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get the employed clinical significance method — get_method","text":"","code":"results <- jacobson_1989 %>% clinical_significance(   id = subject,   time = time,   outcome = gds,   pre = \"pre\",   reliability = 0.80 )  get_method(results) #> [1] \"JT\""},{"path":"/reference/get_n.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Number Of Participants From A clinisig Object — get_n","title":"Get Number Of Participants From A clinisig Object — get_n","text":"Get Number Participants clinisig Object","code":""},{"path":"/reference/get_n.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Number Of Participants From A clinisig Object — get_n","text":"","code":"get_n(x, which = \"all\")"},{"path":"/reference/get_n.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Number Of Participants From A clinisig Object — get_n","text":"x clinisig object n returned? Available options \"\", n original used data set (default) \"original\", n original dataset \"used\", n used data set, conversion wide format omitting cases missing values","code":""},{"path":"/reference/get_n.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Number Of Participants From A clinisig Object — get_n","text":"tibble number participants","code":""},{"path":"/reference/get_n.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Number Of Participants From A clinisig Object — get_n","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  get_n(results) #> # A tibble: 1 × 3 #>   n_original n_used percent_used #>        <int>  <int>        <dbl> #> 1         30     26        0.867 get_n(results, which = \"original\") #> # A tibble: 1 × 1 #>   n_original #>        <int> #> 1         30 get_n(results, which = \"used\") #> # A tibble: 1 × 1 #>   n_used #>    <int> #> 1     26"},{"path":"/reference/get_reliability.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Reliability Of A clinisig Object — get_reliability","title":"Get Reliability Of A clinisig Object — get_reliability","text":"Get Reliability clinisig Object","code":""},{"path":"/reference/get_reliability.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Reliability Of A clinisig Object — get_reliability","text":"","code":"get_reliability(x)"},{"path":"/reference/get_reliability.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Reliability Of A clinisig Object — get_reliability","text":"x clinisig object","code":""},{"path":"/reference/get_reliability.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Reliability Of A clinisig Object — get_reliability","text":"tibble showing reliability","code":""},{"path":"/reference/get_reliability.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Reliability Of A clinisig Object — get_reliability","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  results_nk <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     reliability_post = 0.85,     m_functional = 30,     sd_functional = 10,     type = \"c\",     method = \"NK\"   )  get_reliability(results) #> # A tibble: 1 × 1 #>   reliability #>         <dbl> #> 1         0.8 get_reliability(results_nk) #> # A tibble: 1 × 2 #>   reliability_pre reliability_post #>             <dbl>            <dbl> #> 1             0.8             0.85"},{"path":"/reference/get_summary_table.html","id":null,"dir":"Reference","previous_headings":"","what":"Get A Summary Table From A clinisig Object — get_summary_table","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"Retrieve summary table tidy tibble format. especially useful plot results conduct sensitivity analyses.","code":""},{"path":"/reference/get_summary_table.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"","code":"get_summary_table(x, which = c(\"individual\", \"group\"))"},{"path":"/reference/get_summary_table.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"x clinisig object. level summary table return. necessary method \"HA\" since two summary tables reported. Available individual, default group, group level results according Hageman & Arrindell (1999)","code":""},{"path":"/reference/get_summary_table.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"tibble clinical significance categories","code":""},{"path":"/reference/get_summary_table.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"Hageman, W. J., & Arrindell, W. . (1999). Establishing clinically significant change: increment precision distinction individual group level analysis. Behaviour Research Therapy, 37(12), 1169–1193. https://doi.org/10.1016/S0005-7967(99)00032-7","code":""},{"path":"/reference/get_summary_table.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get A Summary Table From A clinisig Object — get_summary_table","text":"","code":"results <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\"   )  results_ha <- jacobson_1989 %>%   clinical_significance(     id = subject,     time = time,     outcome = gds,     pre = \"pre\",     reliability = 0.80,     m_functional = 30,     sd_functional = 10,     type = \"c\",     method = \"HA\"   )  get_summary_table(results) #> # A tibble: 5 × 3 #>   category         n percent #>   <chr>        <int>   <dbl> #> 1 Recovered        6   0.231 #> 2 Improved         8   0.308 #> 3 Unchanged       12   0.462 #> 4 Deteriorated     0   0     #> 5 Harmed           0   0     get_summary_table(results_ha) #> # A tibble: 5 × 3 #>   category         n percent #>   <chr>        <int>   <dbl> #> 1 Recovered        2  0.0769 #> 2 Improved        15  0.577  #> 3 Unchanged        9  0.346  #> 4 Deteriorated     0  0      #> 5 Harmed           0  0      get_summary_table(results_ha, which = \"group\") #> # A tibble: 2 × 2 #>   category   percent #>   <chr>        <dbl> #> 1 Changed      0.900 #> 2 Functional   0.300"},{"path":"/reference/jacobson_1989.html","id":null,"dir":"Reference","previous_headings":"","what":"Marital Therapy Data — jacobson_1989","title":"Marital Therapy Data — jacobson_1989","text":"dataset containing data Jacobson et al. (1989). purpose study examine two forms behavioral marital therapy,","code":""},{"path":"/reference/jacobson_1989.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Marital Therapy Data — jacobson_1989","text":"","code":"jacobson_1989"},{"path":"/reference/jacobson_1989.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Marital Therapy Data — jacobson_1989","text":"object class tbl_df 60 rows 4 columns. subject Subject ID time Measurement das Dyadic Adjustment Scale score gds Global Distress Scale score","code":""},{"path":"/reference/jacobson_1989.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Marital Therapy Data — jacobson_1989","text":"Jacobson, N. S., Schmaling, K. B., Holtzworth-Munroe, ., Katt, J. L., Wood, L. F., & Follette, V. M. (1989). Research-structured vs clinically flexible versions social learning-based marital therapy. Behaviour Research Therapy, 27(2), 173-180. https://doi.org/10.1016/0005-7967(89)90076-4 Jacobson, N. S., & Truax, P. (1991). Clinical significance: statistical approach defining meaningful change psychotherapy research. Journal Consulting Clinical Psychology, 59(1), 12-19. https://doi.org/10.1037//0022-006X.59.1.12","code":""},{"path":"/reference/pipe.html","id":null,"dir":"Reference","previous_headings":"","what":"Pipe operator — %>%","title":"Pipe operator — %>%","text":"See magrittr::%>% details.","code":""},{"path":"/reference/pipe.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pipe operator — %>%","text":"","code":"lhs %>% rhs"},{"path":"/reference/pipe.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Pipe operator — %>%","text":"lhs value magrittr placeholder. rhs function call using magrittr semantics.","code":""},{"path":"/reference/pipe.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Pipe operator — %>%","text":"result calling rhs(lhs).","code":""},{"path":"/reference/plot.clinisig.html","id":null,"dir":"Reference","previous_headings":"","what":"Plot Clinical Significance Results — plot.clinisig","title":"Plot Clinical Significance Results — plot.clinisig","text":"Plot results clinical significance analysis.","code":""},{"path":"/reference/plot.clinisig.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Plot Clinical Significance Results — plot.clinisig","text":"","code":"# S3 method for clinisig plot(   x,   lower_limit = 0,   upper_limit = 100,   rci_fill = \"grey10\",   rci_alpha = 0.1,   diagonal_color = \"black\",   show = NULL,   which = c(\"point\", \"trajectory\", \"slope\"),   include_cutoff = TRUE,   include_cutoff_band = FALSE,   x_lab = NULL,   y_lab = NULL,   color_lab = \"Group\",   overplotting = 0.02,   ... )"},{"path":"/reference/plot.clinisig.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Plot Clinical Significance Results — plot.clinisig","text":"x clinisig object lower_limit Numeric, lower plotting limit. Defaults 0 upper_limit Numeric, upper plotting limit. Defaults 100 rci_fill String, color (name HEX code) RCI filling rci_alpha Numeric, controls transparency RCI. can value 0 1. diagonal_color String, color (name HEX code) line indicating change. show String. several options color different features. Available \"category\" (shows categories ) default \"recovered\" (shows recovered participants) \"improved\" (shows improved participants) \"unchanged\" (shows unchanged participants) \"deteriorated\" (shows deteriorated participants, available) \"harmed\" (shows harmed participants, available) String. plot type shown? Defaults \"point\" yields default clinical significance plot. HLM method incorporates multiple measurements per participant, reduction pre post values may remove important information. Therefore, can additionally choose plot either participants trajectory (\"trajectory\"), participants fitted Empirical Bayes slope (\"slope\") include_cutoff Logical. clinical cutoff plotted well? Defaults TRUE. include_cutoff_band Logical. method HA, region uncertainty around cutoff can plotted x_lab String, x axis label. Default \"Pre\" point \"Measurement\" trajectory slope plot. y_lab String, y axis label. Default \"Post\" point, \"Outcome Score\" trajectory, \"Fitted Score\" slope plot. color_lab String, color guide label. Default \"Group\". overplotting Numeric, control amount overplotting. Defaults 0.02 (.e., 2% range lower upper limit). ... Additional arguments","code":""},{"path":"/reference/plot.clinisig.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Plot Clinical Significance Results — plot.clinisig","text":"ggplot2 plot","code":""},{"path":"/reference/plot.clinisig.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Plot Clinical Significance Results — plot.clinisig","text":"resulting plot generic clinical significance plot pre-intervention assessment scores x-axis post-intervention assessment scores y-axis. default, cutoff clinical functional population plotted well RCI band.","code":""},{"path":"/reference/print.clinisig.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Clinical Significance Results — print.clinisig","title":"Print Clinical Significance Results — print.clinisig","text":"Print Clinical Significance Results","code":""},{"path":"/reference/print.clinisig.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Clinical Significance Results — print.clinisig","text":"","code":"# S3 method for clinisig print(x, ...)"},{"path":"/reference/print.clinisig.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Print Clinical Significance Results — print.clinisig","text":"x clinisig object ... Additional arguments passed export_table()","code":""},{"path":"/reference/print.clinisig.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Print Clinical Significance Results — print.clinisig","text":"return value, called side effects","code":""},{"path":"/reference/summary.clinisig.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary Method for a clinisig object — summary.clinisig","title":"Summary Method for a clinisig object — summary.clinisig","text":"Summary Method clinisig object","code":""},{"path":"/reference/summary.clinisig.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary Method for a clinisig object — summary.clinisig","text":"","code":"# S3 method for clinisig summary(object, ...)"},{"path":"/reference/summary.clinisig.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary Method for a clinisig object — summary.clinisig","text":"object clinisig object ... Additional arguments","code":""},{"path":"/reference/summary.clinisig.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Summary Method for a clinisig object — summary.clinisig","text":"return value, called side effects","code":""}]
